Study shows broccoli may offer protection against liver cancer
- Details
- Category: Research
Consumption of broccoli has increased in the United States over the last few decades as scientists have reported that eating the vegetable three to five times per week can lower the risk of many types of cancer including breast, prostate, and colon cancers. A new study from the University of Illinois reports that including broccoli in the diet may also protect against liver cancer,
Cancer treatment on a cellular level
- Details
- Category: Research
The most common treatments for cancer are radiation and chemotherapy. However they have side effects and also damage healthy tissues. Moreover, their effectiveness is limited when the cancer has spread through out the body. Researchers at the Niels Bohr Institute are therefore working to develop a gentler treatment that 'tricks' the cancer cells, which would absorb a cytotoxin and therefore be destroyed, while healthy cells would remain unaffected.
First in-human vaccine study for malaria caused by Plasmodium vivax
- Details
- Category: Research
Walter Reed Army Institute of Research (WRAIR) researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model. A vaccine to prevent infection and disease caused by P. vivax is critical to reduce sickness and mortality from vivax malaria, a common cause of malaria among deployed service members.
Single antibody from human survivor protects nonhuman primates against Ebola virus
- Details
- Category: Research
A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protected monkeys from lethal infection with the virus, according to research published in today's online edition of the journal Science. Importantly, the antibody, known as mAb114, was effective even when given five days after exposure to Ebola virus, suggesting that it could hold promise as a potential treatment for human cases of EVD.
Scientists discover secret to promising new cancer drug
- Details
- Category: Research
Australian researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment. Nutlins, which are in early clinical trials for treating blood cancers, sparked interest worldwide for their ability to stop cancer growth by activating the body's natural cancer-suppressing
Many clinical trial results not shared, creating 'blind spot'
- Details
- Category: Research
Less than 40% of the results of clinical trials conducted at leading academic medical centers were shared within two years of completion, Yale School of Medicine researchers report in a new study published in the current issue of the British Medical Journal.
Diabetes drug may prevent recurring strokes
- Details
- Category: Research
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.
More Pharma News ...
- 'Beiging' white fat cells to fight diabetes
- Combination drug targeting opioid system may help relieve treatment-resistant depression
- Plant extract shows promise in treating pancreatic cancer
- Type 2 diabetes drug can exhaust insulin-producing cells
- Some heart drugs and antibiotics show effective in fighting cancer
- Fighting flu with designer drugs: A new compound fends off different influenza strains
- Use of and barriers to access to opioid analgesics worldwide